TV48108 / Teva - LARVOL DELTA

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients (clinicaltrials.gov) - P1; N=61; Terminated; Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.; N=110 ➔ 61; Recruiting ➔ Terminated

Enrollment change • Trial termination • Biosimilar • Chronic Obstructive Pulmonary Disease